Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study

AIDS

Volumn 12, Issue 9, 1998, Pages 1039-1045

  Van Benthem, Birgit H B ^a   Veugelers, Paul J ^b   Cornelisse, Peter G A ^c   Strathdee, Steffanie A ^c   Kaldor, John M ^d   Page Shafer, Kimberly A ^e   Coutinho, Roel A ^a   Van Griensven, Godfried J P ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b Documentation and Health Promotion ^*  (Netherlands)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Homosexual men; Incubation time; Survival after AIDS

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DEATH; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; KAPOSI SARCOMA; LYMPHOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SEROCONVERSION; STATISTICAL ANALYSIS; SURVIVAL;

EID: 0032543651     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199809000-00012     Document Type: Article

References (30)

1. Mocroft A, Johnson MA, Phillips AN: Factors affecting survival in patients with AIDS. AIDS 1996, 10:1057-1065.
2. Hessol NA, Koblin BA, van Griensven CJP, et al.: Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994, 139:1077-1087.
3. Mocroft A, Youle M, Morcinek J, et al: Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. BMJ 1997, 314:409-413.
4. Jacobson LP, Kirby AJ, Polk S, et al.: Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. Am J Epidemiol 1993, 138:952-964.
5. Lemp GF, Payne SF, Neal D, Temelso T, Rutherford GW: Survival trends for patients with AIDS. JAMA 1990, 263:402-406.
6. Lundgren JD, Pedersen C, Clumeck N, et al.: Survival differences in European patients with AIDS, 1979-89. BMJ 1994, 308:1068-1073.
7. Blum S, Singh TP, Gibbons J, et al.: Trends in survival among persons with acquired immunodeficiency syndrome in New York City. Am J Epidemiol 1994, 139:351-361.
8. Seage GR, Oddleifson S, Carr E, et al.: Survival with AIDS in Massachusetts, 1979 to 1989. Am J Public Health 1993, 83:72-78.
9. Luo K, Law M, Kaldor JM, McDonald AM, Cooper DA: The role of initial AIDS-defining illness in survival following AIDS. AIDS 1995, 9:57-63.
10. Chang HGH, Morse DL, Noonan C, et al.: Survival and mortality of an acquired immunodeficiency syndrome (AIDS) cohort in New York state. Am J Epidemiol 1993, 138:341-349.
11. Bacchetti P, Osmond D, Chaisson TE, et al.: Survival patterns of the first 500 patients with AIDS in San Francisco. J Infect Dis 1988, 157:1044-1047.
12. Saah AJ, Hoover DR, He Y, et al.: Factors influencing survival after AIDS: report from the multicenter AIDS cohort study (MACS). J Acquir Immune Defic Syndr 1994, 7:287-295.
13. Mocroft AJ, Lundgren JD, d'Arminio Monforte A, et al.: Survival of AIDS patients according to type of AIDS defining event. Int J Epidemiol 1997, 26:400-406.
14. Bindels PJE, Krol A, Roos M, et al.: The predictive value of T cell function in vitro and pre-AIDS zidovudine use for survival after AIDS diagnosis in a cohort of homosexual men in Amsterdam. J Infect Dis 1995, 172:97-104.
15. Phillips AN, Lee CA, Elford J, et al.: Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991, 337:389-392.
16. Yong FHL, Taylor JMC, Bryant JL, Chmiel JS, Gange SJ, Hoover D: Dependence of the hazard of AIDS on markers. AIDS 1997, 11:217-228.
17. Veugelers PJ, Page KA, Tindall B, et al: Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol 1994, 140:747-758.
18. Schechter MT, Boyko WJ, Jeffries E, et al.: The Vancouver Lymphadenopathy-AIDS Study. Persistent generalized lymphadenopathy. Can Med Assoc J 1985, 132:1273-1279.
19. Tindall B, Swanson CE, Cooper DA: Development of AIDS in a cohort of HIV-seropositive homosexual men in Australia. Med J Aust 1990, 153:260-265.
20. van Criensven GJP, Tielman RAP, Goudsmit J, et al.: Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. Am J Epidemiol 1987, 125:1048-1057.
21. Moss AR, Bachetti P, Osmond D: Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. BMJ 1988, 296:745-750.
22. Winkelstein W, Lyman DM, Padian N, et al.: Sexual practices and risk of infection by the human immunodeficiency virus. JAMA 1987, 257:321-325.
23. van Benthem BHB, Veugelers PJ, Schlechter MT, Kaldor JM, Page-Shafer KA, van Griensven GJP: Modelling the AIDS incubation time: evaluation of three right censoring strategies [letter]. AIDS 1997, 11:834-835.
24. Centers for Disease Control: Revision of the case definition of acquired immune deficiency syndrome. MMWR 1987, 36 (suppl 1S):1S-15S.
25. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17):1-19.
26. Muñoz A, Xu J: Models for the incubation period of AIDS and variations according to age and period. Stat Med 1996, 15:2459-2473.
27. Veugelers PJ, Schechter MT, Tindall B, et al.: Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual men. AIDS 1993, 7:1325-1329.
28. Ghirardini A, Puopolo M, Rossetti G, et al.: Survival after AIDS among Italian haemophiliacs with HIV infection. AIDS 1995, 9:1351-1356.
29. Shi M, Taylor JM, Currier RJ, et al.: Replacing lime since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:309-316.
30. Lundgren JD, Phillips AN, Pedersen C, et al.: Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. JAMA 1994, 271:1088-1092.